Cargando…

The efficacy and safety of immunotherapy in thymic epithelial tumors: more effective, more risky: a systematic review

BACKGROUND: Thymic epithelial tumors (TETs) are rare malignant neoplasms originating from thymic epithelial cells. The current treatment for localized TETs is surgical removal. However, 20–30% of thymomas and 70–80% of thymic carcinomas are unresectable, recurrent, or metastatic at the time of detec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Xinyu, Fan, Jiang, Zhu, Liang, Wang, Zhehai, He, Yayi, Zhou, Caicun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411126/ https://www.ncbi.nlm.nih.gov/pubmed/34527346 http://dx.doi.org/10.21037/jtd-21-290

Ejemplares similares

Immunotherapy and Targeted Therapies Efficacy in Thymic Epithelial Tumors: A Systematic Review
por: Agrafiotis, Apostolos C., et al.
Publicado: (2023)

Immunotherapy of thymic epithelial tumors: molecular understandings and clinical perspectives
por: Ao, Yong-Qiang, et al.
Publicado: (2023)

Balancing the Risk of Adverse Events against the Efficacy of Immunotherapy in Advanced Thymic Epithelial Tumors
por: Ohm, Birte, et al.
Publicado: (2022)

Efficacy of pemetrexed-based regimen in relapsed advanced thymic epithelial tumors and its association with thymidylate synthetase level
por: Qian, Xinyu, et al.
Publicado: (2016)

Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors
por: Tateo, Valentina, et al.
Publicado: (2020)

Immunotherapy for Management of Thymic Epithelial Tumors: A Double-Edged Sword
por: Ballman, Madison, et al.
Publicado: (2022)

The role of immunotherapy for management of advanced thymic epithelial tumors: a narrative review
por: Rajan, Arun, et al.
Publicado: (2021)

Vascular reconstitution in the tumor for more effective tumor immunotherapy
por: Takakura, Nobuyuki
Publicado: (2021)

Recent Progress on Immunotherapy for Breast Cancer: Tumor Microenvironment, Nanotechnology and More
por: Li, Yang, et al.
Publicado: (2021)

Letter to the Editor: Why is influenza virus more risky for pregnant women?
por: Cusi, Maria Grazia
Publicado: (2010)

Are Older Adults More Risky Readers? Evidence From Meta-Analysis
por: Zhang, Jiaqi, et al.
Publicado: (2022)

Could HPV Type 33 Be More Risky Than We Thought?
por: Purut, Yunus Emre, et al.
Publicado: (2022)

Epigenetics of Thymic Epithelial Tumors
por: Nicolì, Vanessa, et al.
Publicado: (2023)

Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated with bispecific antibody
por: Song, Xinyu, et al.
Publicado: (2023)

Gambling formats, involvement, and problem gambling: which types of gambling are more risky?
por: Mazar, Alissa, et al.
Publicado: (2020)

Deciphering the biology of thymic epithelial tumors
por: Rajan, Arun, et al.
Publicado: (2019)

Thymic Epithelial Tumors: An Evolving Field
por: Kuhn, Elisabetta, et al.
Publicado: (2023)

Growth of thymic epithelial tumors and thymic cysts: Differential radiological points
por: Kim, Hyungjin, et al.
Publicado: (2019)

Expression of RAGE and HMGB1 in Thymic Epithelial Tumors, Thymic Hyperplasia and Regular Thymic Morphology
por: Moser, Bernhard, et al.
Publicado: (2014)

Efficacy and safety of immune checkpoint inhibitors (ICIs) combined with antiangiogenic therapy for thymic epithelial tumors (TETs): a retrospective study
por: Xiang, Jing, et al.
Publicado: (2023)

Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes
por: Yang, Jun, et al.
Publicado: (2023)

WT1 as an immunotherapy target for thymic epithelial tumors: a novel method to activate anti-tumor immunity
por: Takahashi, Nobuyuki, et al.
Publicado: (2019)

TIM-3, a promising target for cancer immunotherapy
por: He, Yayi, et al.
Publicado: (2018)

Crested macaque facial movements are more intense and stereotyped in potentially risky social interactions
por: Clark, Peter R., et al.
Publicado: (2022)

WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies
por: Suzuki, Mikito, et al.
Publicado: (2019)

The safety and efficacy of immunotherapy with anti-programmed cell death 1 monoclonal antibody for lung cancer complicated with Mycobacterium tuberculosis infection
por: Shi, Jinpeng, et al.
Publicado: (2021)

Construction of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in thymic epithelial tumors
por: Su, Yongchao, et al.
Publicado: (2022)

Quinolone Safety and Efficacy More Important than Potency
por: Frothingham, Richard
Publicado: (2004)

Novel Biologic Therapies for Thymic Epithelial Tumors
por: Chen, Yuanbin, et al.
Publicado: (2014)

The immune landscape of human thymic epithelial tumors
por: Xin, Zhongwei, et al.
Publicado: (2022)

Emerging therapies in thymic epithelial tumors (Review)
por: Dapergola, Athina, et al.
Publicado: (2023)

Current Treatment Approaches for Thymic Epithelial Tumors
por: Tartarone, Alfredo, et al.
Publicado: (2023)

The more things change ... the more things change: developmental plasticity of tumor-initiating mammary epithelial cells
por: Lewis, Michael T
Publicado: (2010)

CT-Based Radiomics Nomogram for Differentiation of Anterior Mediastinal Thymic Cyst From Thymic Epithelial Tumor
por: Zhang, Chengzhou, et al.
Publicado: (2021)

Searching for Novel Biomarkers in Thymic Epithelial Tumors: Immunohistochemical Evaluation of Hippo Pathway Components in a Cohort of Thymic Epithelial Tumors
por: Palamaris, Kostas, et al.
Publicado: (2023)

Clinical efficacy evaluation of tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations
por: Song, Xinyu, et al.
Publicado: (2017)

Safety and Effectiveness of Transvenous Lead Extraction in Patients with Infected Cardiac Resynchronization Therapy Devices; Is It More Risky than Extraction of Other Systems?
por: Stefańczyk, Paweł, et al.
Publicado: (2022)

Prognostic CT features in patients with untreated thymic epithelial tumors
por: Dai, Haiyang, et al.
Publicado: (2023)

Follistatin impacts Tumor Angiogenesis and Outcome in Thymic Epithelial Tumors
por: Janik, Stefan, et al.
Publicado: (2019)

Tumor Microenvironment in Thymic Epithelial Tumors: A Narrative Review
por: Agrafiotis, Apostolos C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vm7a5cgd4uq5o92bcrrgdj80r7